These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 888832)

  • 1. Drug reaction alerts.
    Lee B; Groth PE
    Am J Hosp Pharm; 1977 Jul; 34(7):694-5. PubMed ID: 888832
    [No Abstract]   [Full Text] [Related]  

  • 2. Food and Drug Administration's adverse drug reaction monitoring program.
    Lee B; Turner WM
    Am J Hosp Pharm; 1978 Aug; 35(8):929-32. PubMed ID: 677138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions. The scene revisited--an update.
    Weston JK; Weston K
    Clin Toxicol; 1977; 10(1):129-48. PubMed ID: 858224
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA as an information source for family physicians.
    Rheinstein PH
    Am Fam Physician; 1991 Sep; 44(3):1037-41. PubMed ID: 1877417
    [No Abstract]   [Full Text] [Related]  

  • 5. The planning of a national drug monitoring system.
    Esch AF
    World Health Organ Tech Rep Ser; 1972; 498():44-7. PubMed ID: 4625551
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug reaction reporting.
    Bosco LA
    Am J Gastroenterol; 1987 Apr; 82(4):356-7. PubMed ID: 3565343
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug therapy monitoring notes--untapped source of data.
    Riddiough MA
    Am J Hosp Pharm; 1978 Mar; 35(3):241, 243. PubMed ID: 626202
    [No Abstract]   [Full Text] [Related]  

  • 8. Reporting adverse drug reaction in a small hospital.
    Magee PE; Garrison TJ
    Hospitals; 1976 Jan; 50(2):63-4, 66-7. PubMed ID: 1245331
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving how we evaluate the toxicity of approved drugs.
    Reidenberg MM
    Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311
    [No Abstract]   [Full Text] [Related]  

  • 10. A perspective on drug reaction reporting.
    Schneller GH
    Am J Pharm Sci Support Public Health; 1974; 146(3):70-4. PubMed ID: 4850260
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing an adverse drug reaction reporting program.
    Nelson RW; Shane R
    Am J Hosp Pharm; 1983 Mar; 40(3):445-6. PubMed ID: 6846354
    [No Abstract]   [Full Text] [Related]  

  • 12. 'Dear doctor...'--evaluating the impact of risk communication efforts.
    Seligman PJ
    Pharmacoepidemiol Drug Saf; 2003 Jun; 12(4):291-3. PubMed ID: 12812008
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug event reporting. Improving the low US reporting rates.
    Edlavitch SA
    Arch Intern Med; 1988 Jul; 148(7):1499-503. PubMed ID: 3382293
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reaction reporting program.
    Knobloch CP
    J Am Vet Med Assoc; 1980 Jan; 176(1):29. PubMed ID: 6892526
    [No Abstract]   [Full Text] [Related]  

  • 15. The Food and Drug Administration Information Center on adverse reactions and hazards.
    Saiger GL
    Pharmakotherapia; 1965; 2(2):124-8. PubMed ID: 5875220
    [No Abstract]   [Full Text] [Related]  

  • 16. Urgent--drug recall. How well does the system work?
    Small WE
    Am Pharm; 1980 Aug; NS20(8):17-9. PubMed ID: 7424773
    [No Abstract]   [Full Text] [Related]  

  • 17. Reporting adverse drug therapy results.
    Pa Med; 1990 Jun; 93(6):29. PubMed ID: 2367135
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug problems in the WHO].
    Lindgren SA
    Lakartidningen; 1966 Jul; 63(28):2641-4. PubMed ID: 5953348
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse drug reactions.
    Fisher RL
    Am J Gastroenterol; 1987 Apr; 82(4):355. PubMed ID: 3565342
    [No Abstract]   [Full Text] [Related]  

  • 20. Beware of new drugs, study suggests.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.